Speakers 3D Bioprinting Session

3d bioprinting

During the 3D Medical Conference, which takes place on 30/31 January 2019 at MECC Maastricht, The Netherlands, the following speakers will present in the 3D Bioprinting Session:

Prasad Shastri, Professor and Director of the Institute for Macromolecular Chemistry, University of Freiburg, Germany, on “BioInks the Lynchpin of 3D Bioprinting: Challenges and Opportunities”, More information

Derek Mathers, Director, Strategic Accounts ,  Advanced Solutions Life Sciences (ASLS) , USA, on “A Precision Workflow for Clinic-based Bioprinting “, More information

Sandra Camarero Espinosa, PhD, Postdoctoral researcher, MERLN institute for Technology Inspired Regenerative Medicine, on “Designing biomaterials for tissue regeneration”, More information

Tom Kamperman, CTO / CEO a.i. @ IamFluidics B.V. & post-doctoral researcher @ University of Twente, on “Microgel Technology to Advance Modular Tissue Engineering”, More information

Jasper van Dieten-Blom, Segment Leader Healthcare, DSM Additive Manufacturing, on “Qualification of Materials for medical applications”, More information

Ernst-Jan Louwers, IP and tech lawyer,  Louwers IP|Technology Advocaten, on “3D medical printing: throw the dice!”, More information

Carlos Mota, PhD, Assistant Professor, Maastricht University /
MERLN Institute for Technology-Inspired Regenerative Medicine, on “Bioprinting of tissues and organs”, More information

Marko Milojevic, Researcher and PhD student, Faculty of Medicine, University of Maribor, Slovenia, on “Core-shell printing of Alginate-CMC scaffolds for engineering of tubular tissues”, More information

For more information about the complete conference program, click here.

If you want to visit the expo, please click on this link.

MERLN Institute and Aspect Biosystems Enter Collaboration to Develop Kidney Tissue

kidney

Aspect Biosystems, a leading biotechnology company in the field of 3D bioprinting and tissue engineering, is pleased to announce a collaboration with the Institute for Technology-Inspired Regenerative Medicine (MERLN) at Maastricht University in the Netherlands. This collaboration includes the placement of an RX1™ Bioprinting Platform in Professor Lorenzo Moroni’s Lab, where it will be used to develop kidney tissue by head of bioprinting research, Dr. Carlos Mota.

Under the terms of the collaborative research agreement, Aspect has an option to further develop and commercialize products based upon the results of the research.

“This is an exciting opportunity,” says Prof. Moroni and Dr. Mota. “Aspect’s microfluidic bioprinting technology is very appealing from a flexibility and modularity perspective. At Maastricht University, we have been investing a lot of energy in developing 3D bioprinted in vitro models, which we consider a first immediate step in gaining the knowledge needed for developing regenerative medicine solutions for complex tissue and organ replacement. We already took our first steps in kidney tissue models and we are particularly excited to apply our expertise with Aspect’s platform technology and join forces with their innovative team, which we expect will accelerate our findings and impact in this space.”

“At Aspect, we are committed to collaborating with leading research groups in tissue engineering and regenerative medicine to realize the broad applicability of our technology,” said Tamer Mohamed, President and CEO of Aspect Biosystems. “Patients on life-saving, but onerous, dialysis treatment are often found waiting for donor organs that are severely limited in supply. Tissue engineers recognize the potential of their work to alleviate this problem, but kidney tissue is complex and extremely challenging to create. There is also a strong need for suitable pre-clinical in vitro kidney models to predict nephrotoxicity and study disease in the biopharmaceutical industry. By combining the deep expertise at MERLN with our microfluidic 3D printing technology, we are increasing our capacity to tackle these kidney-related challenges head-on.”

Dr. Mota will be speaking at the 3D Medical Conference during the 3D Bioprinting Session on Janaury 30, 2019. Click here for the full conference program.